# Treating Central Neuropathic Pain With Low Dose Naltrexone for People With Spinal Cord Injury

> **NCT06723561** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Medical College of Wisconsin** · enrollment: 10 (estimated)

## Conditions studied

- Central Neuropathic Pain
- Spinal Cord Injury

## Interventions

- **DRUG:** 4.5mg daily dose of naltrexone

## Key facts

- **NCT ID:** NCT06723561
- **Lead sponsor:** Medical College of Wisconsin
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-02-01
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06723561

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06723561, "Treating Central Neuropathic Pain With Low Dose Naltrexone for People With Spinal Cord Injury". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT06723561. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*